The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correction to The Heart Outcomes Prevention Evaluation Study Investigators, N Engl J Med 342(3):145-153 January 20, 2000.

Correction
PreviousPrevious
Volume 342:748 March 9, 2000 Number 10

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

 

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by The Heart Outcomes Prevention Evaluation Study Investigators
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients . On page 145, in line 16 of the Results paragraph of the Abstract, the relative risk of cardiac arrest should have been 0.62; P = 0.02, not 0.63;P = 0.03, as printed. On page 151, the sentence that begins four lines from the bottom of the left-hand column should have read, "We also observed a reduction in the incidence of heart failure in patients with no evidence of impairment of left ventricular systolic function," not "left ventricular systolic dysfunction," as printed. On page 152, in the Appendix, P. Talbot should be added to the list of investigators from Quebec, and L. di Gerogio should be spelled L. di Giorgio.


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.